Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its wide range of generic and branded pharmaceuticals, has here been facing headwinds in recent quarters. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international firms. A fina